|
|
Parkinson’s Disease " Updates in Diagnosis and Patient Management
Parkinson's disease is a neurodegenerative disorder, second only in prevalence to Alzheimer’s disease. Numerous therapeutic options, including carbidopa/levodopa, monoamine oxidase-B inhibitors, dopamine agonists, and device-assisted therapies, are available for treatment. These treatments are indicated at different stages following diagnosis. However, Parkinson’s disease progresses at highly variable rates, and no biomarkers, laboratory tests, or gold standard indexes are available t... |
|
|
Dysphagia: The Team Approach to Best Practice
Dysphagia: The Team Approach to Best Practice is a 1-hour online continuing education (CE) course that focuses on the interdisciplinary team approach to identifying, treating and managing dysphagia.
Dysphagia is a wide spread problem in the elderly, with many going untreated. Older adults are at an increased risk due to having many factors that lead to swallowing difficulties. Some of these are a diagnosis of stroke, dementia, pneumonia and Parkinson’s disease. Many have generalized weakn... |
|
|
Evidence Based Cognitive Communication Treatment-Parkinsons Patients - Aimee Mooney, MS, CCC-SLP
Parkinsons Disease is a chronic and progressive neurodegenerative disease that affects 1.5 million people with an additional 60,000 new diagnoses made annually. Over 85 percent of the diagnoses are made in individuals over age 50. With the Baby Boomers increasing in age, Speech and Language Pathologists need to be ready to treat this population.
The presentation of the disease is individualized and multifaceted, including both motor and non motor symptoms. It is unpredictable and complex, ... |
|